U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ELUVIXTAMAB
USAN   INN  
Official Name English
AMG-330
Preferred Name English
IMMUNOGLOBULIN, ANTI-(HUMAN SIALIC ACID-BINDING IG-LIKE LECTIN 3) (HUMAN MONOCLONAL 1803MNGSSMABC SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSI
Common Name English
A CD33/CD3 BISPECIFIC T-CELL ENGAGER ANTIBODY FOR ACUTE MYELOID LEUKEMIA THERAPY
Common Name English
eluvixtamab [INN]
Common Name English
AMG330
Code English
IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS CD33 (SIALIC ACID BINDING IG-LIKE LECTIN 3, SIGLEC3, SIGLEC-3, GP67, P67)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON)), MONOCLONAL ANTIBODY SINGLE CHAIN, BISPECIFIC; IG SCFV-SCFV SINGLE CHAIN, ANTI-CD33 AND ANT
Common Name English
ELUVIXTAMAB [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 691519
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
Code System Code Type Description
USAN
JK-133
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
FDA UNII
6Z4B5PJ4OP
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
SMS_ID
300000028757
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
CAS
1679391-73-1
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
NCI_THESAURUS
C123332
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
INN
11240
Created by admin on Wed Apr 02 03:14:58 GMT 2025 , Edited by admin on Wed Apr 02 03:14:58 GMT 2025
PRIMARY
ACTIVE MOIETY
ELUVIXTAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966